These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36056823)

  • 1. Conglomeration of T- and B-Cell Matrix Responses Determines the Potency of Human Bone Marrow Mesenchymal Stromal Cells.
    Porter AP; Pirlot BM; Dyer K; Uwazie CC; Nguyen J; Turner C; Rajan D; Hematti P; Chinnadurai R
    Stem Cells; 2022 Dec; 40(12):1134-1148. PubMed ID: 36056823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemokine Assay Matrix Defines the Potency of Human Bone Marrow Mesenchymal Stromal Cells.
    Lipat AJ; Cottle C; Pirlot BM; Mitchell J; Pando B; Helmly B; Kosko J; Rajan D; Hematti P; Chinnadurai R
    Stem Cells Transl Med; 2022 Sep; 11(9):971-986. PubMed ID: 35881077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potency Analysis of Mesenchymal Stromal Cells Using a Combinatorial Assay Matrix Approach.
    Chinnadurai R; Rajan D; Qayed M; Arafat D; Garcia M; Liu Y; Kugathasan S; Anderson LJ; Gibson G; Galipeau J
    Cell Rep; 2018 Feb; 22(9):2504-2517. PubMed ID: 29490284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potency Analysis of Mesenchymal Stromal Cells Using a Phospho-STAT Matrix Loop Analytical Approach.
    Chinnadurai R; Rajakumar A; Schneider AJ; Bushman WA; Hematti P; Galipeau J
    Stem Cells; 2019 Aug; 37(8):1119-1125. PubMed ID: 31108008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A streamlined proliferation assay using mixed lymphocytes for evaluation of human mesenchymal stem cell immunomodulation activity.
    Herzig MC; Delavan CP; Jensen KJ; Cantu C; Montgomery RK; Christy BA; Cap AP; Bynum JA
    J Immunol Methods; 2021 Jan; 488():112915. PubMed ID: 33212091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microvescicles derived from mesenchymal stromal cells are not as effective as their cellular counterpart in the ability to modulate immune responses in vitro.
    Conforti A; Scarsella M; Starc N; Giorda E; Biagini S; Proia A; Carsetti R; Locatelli F; Bernardo ME
    Stem Cells Dev; 2014 Nov; 23(21):2591-9. PubMed ID: 24937591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A reproducible immunopotency assay to measure mesenchymal stromal cell-mediated T-cell suppression.
    Bloom DD; Centanni JM; Bhatia N; Emler CA; Drier D; Leverson GE; McKenna DH; Gee AP; Lindblad R; Hei DJ; Hematti P
    Cytotherapy; 2015 Feb; 17(2):140-51. PubMed ID: 25455739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of human mesenchymal stromal cells with peripheral blood mononuclear cells in a Mitogenic proliferation assay.
    Herzig MC; Christy BA; Montgomery RK; Delavan CP; Jensen KJ; Lovelace SE; Cantu C; Salgado CL; Cap AP; Bynum JA
    J Immunol Methods; 2021 May; 492():113000. PubMed ID: 33609532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cells from umbilical cord matrix, adipose tissue and bone marrow exhibit different capability to suppress peripheral blood B, natural killer and T cells.
    Ribeiro A; Laranjeira P; Mendes S; Velada I; Leite C; Andrade P; Santos F; Henriques A; Grãos M; Cardoso CM; Martinho A; Pais M; da Silva CL; Cabral J; Trindade H; Paiva A
    Stem Cell Res Ther; 2013 Oct; 4(5):125. PubMed ID: 24406104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppressive capacity of mesenchymal stem cells correlates with metabolic activity and can be enhanced by valproic acid.
    Killer MC; Nold P; Henkenius K; Fritz L; Riedlinger T; Barckhausen C; Frech M; Hackstein H; Neubauer A; Brendel C
    Stem Cell Res Ther; 2017 Apr; 8(1):100. PubMed ID: 28446224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ruxolitinib Inhibits IFNγ Licensing of Human Bone Marrow Derived Mesenchymal Stromal Cells.
    Ryan MM; Patel M; Hogan K; Lipat AJ; Scandolara R; Das R; Bruker C; Galipeau J; Chinnadurai R
    Transplant Cell Ther; 2021 May; 27(5):389.e1-389.e10. PubMed ID: 33965175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic Chondrogenic Mesenchymal Stromal Cells Alter Helper T Cell Subsets in CD4+ Memory T Cells.
    Kiernan CH; Asmawidjaja PS; Fahy N; Witte-Bouma J; Wolvius EB; Brama PAJ; Lubberts E; Farrell E
    Tissue Eng Part A; 2020 May; 26(9-10):490-502. PubMed ID: 31797740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative activation suppression assay to evaluate human bone marrow-derived mesenchymal stromal cell potency.
    Salem B; Miner S; Hensel NF; Battiwalla M; Keyvanfar K; Stroncek DF; Gee AP; Hanley PJ; Bollard CM; Ito S; Barrett AJ
    Cytotherapy; 2015 Dec; 17(12):1675-86. PubMed ID: 26422657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular Endothelial Growth Factor secretion and immunosuppression are distinct potency mechanisms of Human Bone Marrow Mesenchymal Stromal Cells.
    Faircloth TU; Temple S; Parr RN; Tucker AB; Rajan D; Hematti P; Kugathasan S; Chinnadurai R
    Stem Cells; 2024 Jun; ():. PubMed ID: 38826008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inducible indoleamine 2,3-dioxygenase 1 and programmed death ligand 1 expression as the potency marker for mesenchymal stromal cells.
    Guan Q; Li Y; Shpiruk T; Bhagwat S; Wall DA
    Cytotherapy; 2018 May; 20(5):639-649. PubMed ID: 29548707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term assays for mesenchymal stromal cell immunosuppression of T-lymphocytes.
    Herzig MC; Christy BA; Montgomery RK; Cantu-Garza C; Barrera GD; Lee JH; Mucha N; Talackine JR; Abaasah IA; Bynum JA; Cap AP
    Front Immunol; 2023; 14():1225047. PubMed ID: 37822938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adaptive Regulation of Osteopontin Production by Dendritic Cells Through the Bidirectional Interaction With Mesenchymal Stromal Cells.
    Scutera S; Salvi V; Lorenzi L; Piersigilli G; Lonardi S; Alotto D; Casarin S; Castagnoli C; Dander E; D'Amico G; Sozzani S; Musso T
    Front Immunol; 2018; 9():1207. PubMed ID: 29910810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signature quality attributes of CD146
    Bowles AC; Kouroupis D; Willman MA; Perucca Orfei C; Agarwal A; Correa D
    Stem Cells; 2020 Aug; 38(8):1034-1049. PubMed ID: 32379908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stem cells inhibit T-cell function through conserved induction of cellular stress.
    Laing AG; Fanelli G; Ramirez-Valdez A; Lechler RI; Lombardi G; Sharpe PT
    PLoS One; 2019; 14(3):e0213170. PubMed ID: 30870462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IDO-independent suppression of T cell effector function by IFN-γ-licensed human mesenchymal stromal cells.
    Chinnadurai R; Copland IB; Patel SR; Galipeau J
    J Immunol; 2014 Feb; 192(4):1491-501. PubMed ID: 24403533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.